Irritable Bowel Syndrome, Gut Microbiota and Probiotics

Ulcerative colitis and irritable bowel patients exhibit distinct abnormalities of the gut microbiota

(2011) Samah O Noor et al.   BMC GASTROENTEROLOGY

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

(2011) Mark Pimentel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid

(2011) M. Mohamadzadeh et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Differential Expression of Toll-Like Receptors in Patients With Irritable Bowel Syndrome

(2010) Elizabeth K Brint et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Human-derived probiotic Lactobacillus reuteri strains differentially reduce intestinal inflammation

(2010) Yuying Liu et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Probiotic bacteria and intestinal epithelial barrier function

(2010) Christina L. Ohland et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

Intestinal Bacteria and the Regulation of Immune Cell Homeostasis

(2010) David A. Hill et al.   Annual Review of Immunology

Effect of Probiotics on Symptoms in Korean Adults with Irritable Bowel Syndrome

(2010) Kyoung Sup Hong et al.   Gut and Liver

Immunomodulation by Commensal and Probiotic Bacteria

(2010) Paul Forsythe et al.   IMMUNOLOGICAL INVESTIGATIONS

Effect of Acute Mucosal Exposure to Lactobacillus rhamnosus GG on Human Colonic Smooth Muscle Cells

(2010) Michele Pier Luca Guarino et al.   JOURNAL OF CLINICAL GASTROENTEROLOGY

Gastrointestinal microbiota in irritable bowel syndrome: present state and perspectives

(2010) A. Salonen et al.   MICROBIOLOGY-SGM

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

(2010) Lena Öhman et al.   Nature Reviews Gastroenterology & Hepatology

Microbiota restoration: natural and supplemented recovery of human microbial communities

(2010) Gregor Reid et al.   NATURE REVIEWS MICROBIOLOGY

The probiotic Bifidobacterium infantis 35624 displays visceral antinociceptive effects in the rat

(2010) D. P Mckernan et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Treating irritable bowel syndrome with probiotics: the evidence

(2010) G. C. Parkes et al.   PROCEEDINGS OF THE NUTRITION SOCIETY

Has the Microbiota Played a Critical Role in the Evolution of the Adaptive Immune System?

(2010) Y. K. Lee et al.   SCIENCE

Current and emerging therapies in irritable bowel syndrome: from pathophysiology to treatment

(2010) Joseph Y. Chang et al.   TRENDS IN PHARMACOLOGICAL SCIENCES

Association of symptoms with gastrointestinal microbiota in irritable bowel syndrome

(2010) Erja Malinen   WORLD JOURNAL OF GASTROENTEROLOGY

Current insights in to the pathophysiology of Irritable Bowel Syndrome

(2010) Theodoros Karantanos et al.   Gut Pathogens

Frequency of Small Intestinal Bacterial Overgrowth in Patients with Irritable Bowel Syndrome and Chronic Non-Specific Diarrhea

(2010) Uday C. Ghoshal et al.   Journal of Neurogastroenterology and Motility

Post-Infectious Irritable Bowel Syndrome, an Inflammation-Immunological Model with Relevance for Other IBS and Functional Dyspepsia

(2010) Kok-Ann Gwee   Journal of Neurogastroenterology and Motility

The Utility of Probiotics in the Treatment of Irritable Bowel Syndrome: A Systematic Review

(2009) Darren M Brenner et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

T-Cell Activation in Patients With Irritable Bowel Syndrome

(2009) Lena Öhman et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Elevated Human β-Defensin-2 Levels Indicate an Activation of the Innate Immune System in Patients With Irritable Bowel Syndrome

(2009) Jost Langhorst et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli

(2009) Xuelian Ma et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome

(2009) Nourieh Hoveyda et al.   BMC GASTROENTEROLOGY

Microbial community analysis reveals high level phylogenetic alterations in the overall gastrointestinal microbiota of diarrhoea-predominant irritable bowel syndrome sufferers

(2009) Lotta Krogius-Kurikka et al.   BMC GASTROENTEROLOGY

Review of rifaximin as treatment for SIBO and IBS

(2009) Mark Pimentel   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Lactobacillus reuterienhances excitability of colonic AH neurons by inhibiting calcium-dependent potassium channel opening

(2009) Wolfgang A. Kunze et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

B-cell activation in patients with irritable bowel syndrome (IBS)

(2009) l. öhman et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Cell-free supernatants ofEscherichia coliNissle 1917 modulate human colonic motility: evidence from anin vitroorgan bath study

(2009) f. bär et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Functional protease-activated receptors in the dorsal motor nucleus of the vagus

(2009) h. wang et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Probiotics promote gut health through stimulation of epithelial innate immunity

(2009) C. Pagnini et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Lower Bifidobacteria counts in both duodenal mucosa-associated and fecal microbiota in irritable bowel syndrome patients

(2009) Angèle PM Kerckhoffs et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Randomized Controlled Treatment Trial of Irritable Bowel Syndrome with a Probiotic E.-coli Preparation (DSM17252) Compared to Placebo

(2009) P Enck et al.   ZEITSCHRIFT FUR GASTROENTEROLOGIE

Clinical trial: effect of active lactic acid bacteria on mucosal barrier function in patients with diarrhoea-predominant irritable bowel syndrome

(2008) J. ZENG et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical trial: a multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study

(2008) E. A. WILLIAMS et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Alterations in Mucosal Immunity Identified in the Colon of Patients With Irritable Bowel Syndrome

(2008) Jeroen Aerssens et al.   Clinical Gastroenterology and Hepatology

Probiotics in functional gastrointestinal disorders: what are the facts?

(2008) E QUIGLEY   CURRENT OPINION IN PHARMACOLOGY

Therapeutic Effect of Lactobacillus acidophilus-SDC 2012, 2013 in Patients with Irritable Bowel Syndrome

(2008) Dong Hyun Sinn et al.   DIGESTIVE DISEASES AND SCIENCES

A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome

(2008) S. Drouault-Holowacz et al.   GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

(2008) P. Moayyedi et al.   GUT

Mechanisms of action of probiotics: Recent advances

(2008) S. C. Ng et al.   INFLAMMATORY BOWEL DISEASES

The alteration of enterochromaffin cell, mast cell, and lamina propria T lymphocyte numbers in irritable bowel syndrome and its relationship with psychological factors

(2008) Kwang Jae Lee et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Antibodies to flagellin indicate reactivity to bacterial antigens in IBS patients

(2008) a. m. schoepfer et al.   NEUROGASTROENTEROLOGY AND MOTILITY

A mixture ofEscherichia coli(DSM 17252) andEnterococcus faecalis(DSM 16440) for treatment of the irritable bowel syndrome - A randomized controlled trial with primary care physicians

(2008) p. enck et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Commensal microbiota is fundamental for the development of inflammatory pain

(2008) F. A. Amaral et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Meta-analysis of probiotics for the treatment of irritable bowel syndrome

(2008) Lynne V McFarland et al.   WORLD JOURNAL OF GASTROENTEROLOGY